Skip to main content

Table 2 Characteristics at ventilator-associated pneumonia onset in full population (learning and validation cohorts)

From: Prediction of pulmonary aspergillosis in patients with ventilator-associated pneumonia

Variables

Bacterial VAP

Acquired pulmonary aspergillosis

p-value

 

n = 176

n = 39

 

Data regarding VAP

   

 Time from admission to VAP, days

8 [5–12]

10 [4–14]

0.599

 Purulent sputum at onset—no. (%)

136 (77.3)

19 (48.7)

 < 0.001

 Body temperature at onset, °C

38.70 [38.10–39]

38.50 [38–38.60]

0.046

 White blood cell count at onset, G/L

12 [9.91–16.50]

10.36 [7.78–13.25]

0.014

 PaO2/FiO2 at onset, mmHg

180 [132.50–241.50]

175 [125–221.14]

0.825

 Septic shock at onset—no. (%)

53 (34.0)

9 (25.7)

0.457

 New pulmonary infiltrate at onset—no. (%)

67 (38.0)

18 (46.1)

0.350

 Polymicrobial VAP—no. (%)

56 (31.8)

17 (43.6)

0.223

  1. SC standard care, MSD multiple site decontamination, ICU intensive care unit, COVID-19 SARS-COV 2 associated infection disease, VAP ventilator-associated pneumonia